Abstract
Gut bacteria might play an important role in male reproductive disorders, such as male infertility and sperm abnormalities; however, their causal role is unclear. Herein, Mendelian randomization (MR)-Egger, weighted median, inverse variance weighting, Simple mode, and Weighted mode were used to test the causal relationship between gut microbes and male reproductive diseases. The MR results were validated using various metrics. The MR results were also consolidated using reverse causality speculation, conducted using two-way MR analysis and Steiger filtering. Biological function was analysed using enrichment analyses. The results suggested that eight intestinal microflorae were causally associated with male infertility. The Eubacterium oxidoreducens group was associated with an increased risk of male infertility, while the family Bacteroidaceae was negatively associated with male reproductive diseases. Eight intestinal microflorae were causally associated with abnormal spermatozoa. The family Streptococcaceae was associated with a high risk of abnormal spermatozoa, whereas the family Porphyromonadaceae was associated with a low risk of abnormal spermatozoa. No pleiotropy was observed, this study identified a high correlation between the gut flora and the likelihood of male reproductive diseases. Future research will attempt to advance microbial-focused treatments for such diseases.
Similar content being viewed by others
Introduction
Clinical infertility is commonly defined as the persistent inability of a couple to achieve pregnancy after 12 months of active attempts to conceive. Approximately 30–50% of these cases are associated with male infertility due to a variety of causes1. Primary male infertility is usually caused by congenital developmental anomalies, such as mutations in the CFTR gene (encoding cystic fibrosis transmembrane conductance regulator) leading to a congenital absence of the vas deferens and microdeletions of the Y chromosome at the azoospermia locus2. Secondary male infertility is often caused by acquired factors, including medical injury, reproductive tract infections, and poor lifestyle3. Most infertile men have problems with the quality of their sperm, the quantity of sperm production, or both. Common clinical conditions such as azoospermia, oligospermia, hypocupremia, and sperm incompetence are summarized under the term sperm abnormalities. Frequently, the issue can be rectified by changing their lifestyle, drug treatment, or using assisted reproductive technology4.
Intestinal microorganisms can be functionally divided into three main groups: commensal, probiotic, and pathogenic microorganisms, which mainly comprise bacteria, but also include fungi, viruses, and phages, which maintain a dynamic balance in the human intestines5. This large microbial community in the gut has become an important acquired “organ” that is inextricably linked to the human body through long-term co-evolution with the host6. The gut microbiota performs a variety of functions, including metabolism, biological barriers, immune regulation, and host defence7. The intestinal microorganisms not only help the body absorb nutrients from food, but also synthesize amino acids, organic acids, vitamins, and antibiotics8. They can also metabolize the toxins produced by pathogenic bacteria, thus reducing their toxicity to the human body. Therefore, gut microbes are considered the second genome of the human body9. Together with the human genome, the genome of the gut microbiome influences our health in various ways through interactions with environmental factors10. Commensal Lactobacilli were observed to enhance sperm qualitative parameters in dogs11. Moreover, the intestinal microbiota plays an important role in the fertility of hens storing sperm12. In addition, the gut microbiome can influence spermatogenesis by controlling and metabolizing androgens and influencing the blood–testis barrier. It also raises serum levels of trimethylamine N-oxide (TMAO), which can cause vascular inflammation and erectile dysfunction13. Furthermore, some researchers have used tretinoin-induced testicular injury of mice to investigate the connection between intestinal microbes and testicular dysfunction. They discovered that the gut flora primarily aided the restoration of testicular injuries by controlling the metabolism of polyamines. However, in many previous studies, most of which were observational, the relationship between the gut flora and male reproductive disorders was also influenced by confounding factors, such as age, environment, dietary habits, and lifestyle. These circumstances have limited the investigation of causality between the gut microbiota and male infertility.
Mendelian randomization (MR)14 is an epidemiological method used to analyse causal relationships between traits. The core of MR is based on the law of independent gametes, which states that the assignment of genes is random when parents with multiple pairs of traits cross to produce gametes. Genotype determines phenotype; therefore, MR studies use genetic variation as an instrumental variable of exposure to explore its causal relationship with outcomes15. Randomized classification and constant germline genotypes in MR reduce the impact of confounding by reverse causation, as well as confounding factors, such as the environment, lifestyle, and dietary habits. These factors tend to detract from traditional observational studies and significantly affect the inference of causal relationships between risk factors and outcomes16. The data used for the MR approach are based on genome-wide association studies (GWAS). In MR, single nucleotide polymorphisms (SNPs) are used as instrumental variables (IVs) to infer causal relationships between exposure factors and endpoints17. No published studies have fully elucidated the causal relationship between the gut flora and male reproductive diseases.
In this study, we used a two-sample MR study to investigate whether there is a causal relationship between the gut microbiota and male reproductive diseases. The findings of this investigation might yield new ideas for disease therapy.
Methods
Study design
We used a two-sample MR design based on summary GWAS statistics to provide compelling evidence for a causal relationship between the gut microbiota and male infertility. The role of the gut microbiota in male reproductive diseases was investigated at five levels (phylum, class, order, family, and genus). In addition, Fig. 1 shows that the study design is consistent with three hypotheses: (1) IVs are strongly associated with the exposure of interest; (2) genetic instrumentation is independent of potential confounding factors; and (3) IVs influence outcomes only through the pathway of exposure factors18.
Data sources
Gut microbiome
Summary statistics from a GWAS of the human gut microbiome were extracted from The MiBioGen project (http://www.mibiogen.org)19, which is a large-scale, multiethnic GWAS investigation that recruited 18, 340 people (24 cohorts) from various nations with 122,110 loci of variation. A total of 211 taxa were classified into five biological groups: 9 phyla, 16 classes, 20 orders, 35 families, and 131 genera20. Most of the participants in this study were the United States, Europe (including the United Kingdom, Germany, the Netherlands, and Denmark), and Korea. The microbial composition of the V4, V3–V4, and V1–V2 variable regions of the 16S rRNA gene was investigated and identified using direct taxonomic grading. The microbiota quantitative trait locus (mbQTL) positioning analysis revealed host genetic variation connected with genetic loci related to the abundance of bacterial taxa in the gut microbiota. MiBioGen has standardised all the methods and protocols required to analyse the cohort, such as microbiome data processing, genotype data processing, genome-wide association analysis, and meta-analyses. This standardization has contributed to the trustworthiness and authenticity of the records, allowing robust prospective analysis.
GWAS summary data for diseases
The GWAS summary datasets for male infertility were retrieved from the IEU OpenGWAS database. The diagnostic criteria of male infertility was based on the 10th code of the International Classification of Diseases and GWAS ID finn-b-N14_MALEINFERT, which included 680 cases and 72,799 controls21. Abnormal spermatozoa cases were diagnosed according to the WHO Laboratory Manual for the Examination and Preparation of Human Semen. The GWAS data for abnormal sperm was also acquired from the IEU Open GWAS project, which included 915 cases and 209,006 controls of European ancestry22. The GWAS ID was finn-b-R18_ABNORMAL_SPERMATOZ.
There was no significant overlap between gut microbiota and male reproductive diseases samples. The original GWAS were all approved by their respective agencies. All data used in our study is publicly available. No additional ethical approval is required.
Selection of IVs
The criteria were as follows: (1) SNPs with a genome-wide motif significance threshold (p < 1.0 × 10–5) were selected as potential IVs23. (2) Human genome GRCh38 data were used as reference data to exclude SNPs with linkage disequilibrium (LD) effects (r2 < 0.001, clump kb = 10,000 kb). Proxy SNPs were not searched by default if a specific SNP was not available in the resulting GWAS. Echo SNPs were also excluded24. (3) The intensity of included IVs was assessed using F-statistics and R225. R2 reflects the degree of exposure explained by the IVs and is calculated as R2 = 2 × EAF × (1 − EAF) × b2/[2 × EAF × (1 − EAF) × b2 + 2 × EAF × (1 − EAF) × N × SE(b2)] (EAF: effect allele frequency, SE: standard error of effect size, b: effect size, N: sample size). The F-statistic was calculated according to the formula F = R2 × (N − 2)/(1 − R2) (N: sample size), where the weak instrumental bias is relatively small and the F-statistic is greater than 10 (MR assumption I)26. SNPs that were significantly associated with the outcomes (p < 5e−8) were excluded (MR hypothesis III). We screened all eligible SNPs using PhenoScanner (http://www.phenoscanner.medschl.cam.ac.uk/) with filtering according to r2 > 0.8 and p < 1 × 1 0–5 to exclude SNPs associated with confounding factors (MR hypothesis II)27.
MR analysis
In this study, we used inverse variance weighting (IVW), MR-Egger regression, weighted median, weighted model, and simple mode to test whether there is a causal relationship between the gut flora and the risk of male infertility. The IVW method was the earliest and most commonly used method, which requires the SNPs to be fully consistent with the three principles of the MR study to obtain a correct causal estimate. It is characterized by regressions that do not take into account the presence of an intercept term and are adjusted using the inverse of the variance of the outcome (the squared value of SE) as weights to obtain an overall estimate of the impact of the gut microbiota on the disease28. The major difference between the MR-Egger method and IVW is that the regression takes into account the presence of an intercept term and uses the inverse of the variance of the outcome (the squared value of SE) as a weighting factor for the adjustment. If the intercept term is zero, there is no horizontal pleiotropy and the results of the MR-Egger regression are compatible to those of IVW29. The weighted median method combines the results of several MR estimates. This method weights the causal effects of different genetic variants on a trait and then uses the weighted median as the final estimate of the causal effect. The weighted median method is robust and can reduce bias caused by variation in the estimation results of specific genetic variants30. The weighted mode and the simple mode are also commonly used for MR of causality. The ability to detect causal effects is lower than the IVW and weighted median methods, but greater than that of the MR-Egger method.
Sensitivity analysis
This study tested heterogeneity using sensitivity analysis employing Cochran’s Q-test31. The MR-Egger regression test was used to detect pleiotropy Horizontal multinomiality is present if the intercept is not zero. Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO) reduces horizontal pleiotropy by detecting and removing final outliers32. A leave-one-out sensitivity analysis was performed to check the robustness of the results by removing one SNP at a time. All statistical analyses were performed using the packages “Two Sample MR” and “MR-PRESSO” in R version 4.3.033.
Reverse causality analysis
To evaluate the causal relationship between the gut microbiota and disease, we also performed reverse MR analysis for the bacteria that were found to be causally associated with disease in the forward MR analysis. The methods and settings used were the same as those for forward MR.
Enrichment analysis
To thoroughly examine the physiological impact of the gut microbiota on two male reproductive diseases, we performed an enrichment analysis based on lead SNPs for the chosen gut microbiota34. We mapped causative microbial lead SNPs to neighbouring genes using the GWAS4D website (http://www.mulinlab.org/varnote/index.html)35. Next, we conducted an enrichment analysis using the Metascape website (https://metascape.org). Clusters were created by grouping significantly enriched phrases with p < 0.01, the least number > 3, and an enrichment factor > 1.536.
Ethics statement
This human research did not require ethical approval as we used publicly available data approved by competent ethical and institutional review boards. This research was carried out in compliance with local legal and institutional guidelines. According to national legislation and institutional standards, written informed consent from the participants or their legal guardians/next of kin was not required for this study.
Results
Instrumental variables selection
Using the entire locus statistical significance criterion (p < 1 × 10–5), 2256 SNP were retrieved. No genus had a single SNP in each of the resulting datasets. There was no indication of mild instrumental bias in the current investigation because all the IVs’ F statistic values were higher than 10. Supplementary Tables 1A and 2A include comprehensive details on the effect alleles, other alleles, beta, SE, and p-values for the IVs. We evaluated each genus’s causal influence on the resultant data.
Mendelian randomization and sensitivity analysis of the association between the gut microbiota and male infertility
The IVW method identified eight bacterial genera that might be causally associated with male infertility (Supplementary Table 1B–F). Among them, five bacterial genera were negatively associated with male infertility, suggesting a potential protective effect against male infertility: the family Bacteroidaceae (id.918) (odds ratio (OR) 0.34, 95% confidence interval (CI) 0.15–0.73, p = 0.006); the family Pasteurellaceae (id.368)9 (OR 0.61, 95% CI 0.42–0.89, p = 0.01); the genus Bacteroides (id.918) (OR 0.34, 95% CI 0.15–0.73, p = 0.006); the genus Ruminococcaceae NK4A214 group (id.11358) (OR 0.54, 95% CI 0.29–0.99, p = 0.045); and the order Pasteurellales (id.3688) (OR 0.61, 95% CI 0.42–0.89, p = 0.010). In addition, three bacterial genera were positively associated with male infertility: the genus Lactococcus (id.1851) (OR 1.45, 95% CI 1.01–2.06, p = 0.042); the genus Eubacterium oxidoreducens group (id.11339) (OR 2.05, 95% CI 1.20–3.49, p = 0.008); and the genus Eubacterium ventriosum group (id.11341) (OR 1.66, 95% CI 0.98–2.83, p = 0.061) (Figs. 2, 4). Similar risk estimates were obtained in this study using the MR-Egger, weighted median, weighted model, and simple mode methods, although sometimes these associations were not statistically significant. The p-values for the Cochran Q-test and MR-Egger intercept test were larger than 0.05, showing that there was no heterogeneity or multiplicity in this investigation (Fig. 2, Supplementary Fig. 1A–C).
Mendelian randomization and sensitivity analysis between the gut microbiota and abnormal spermatozoa
For abnormal spermatozoa, IVW initially identified eight bacterial genera with potential causal effects on abnormal spermatozoa (Supplementary Table 2B–F). Two bacterial genera were negatively associated with the likelihood of abnormal spermatozoa, including the family Porphyromonadaceae (id.943) (OR 0.38, 95% CI 0.20–0.71, p = 0.003) and the genus Prevotella9 (id.11183) (OR 0.66, 95% CI 0.46–0.94, p = 0.02); six bacterial genera were negatively correlated with abnormal spermatozoa, suggesting that they have a protective effect against abnormal spermatozoa, including the class Erysipelotrichia (id.2147) (OR 1.77, 95% CI 1.03–3.03, p = 0.038); ebi-a-GCST90016952 (family Streptococcaceae; id.1850) (OR 2.54, 95% CI 1.50–4.31, p = 0.001); the genus Lachnospiraceae UCG001 (id.11321) (OR 1.59, 95% CI 1.07–2.3, p = 0.02); the genus Ruminococcaceae UCG009 (id.11366) (OR 1.44, 95% CI 1.02–2.04, p = 0.04); the genus Streptococcus (id.1853) (OR 2.31,95% CI 1.38–3.88, p = 0.002); and the order Erysipelotrichales (id.2148) (OR 1.77, 95% CI 1.03–3.03, p = 0.04) (Figs. 3, 4, 5). In summary, the IVW estimates were significant (p < 0.05), and the dependability of the results was confirmed by the consistent direction of IVW, MR-Egger, weighted median, weighted model, and simple mode. The results were strong because the p-values of the MR-Egger intercepts for each of the eight bacterial genera were higher than 0.05 (Supplementary Fig. 2A–C).
Reverse MR analysis
To determine whether reverse causality existed, we performed MR analyses to determine reverse causality between each of the two Male reproductive diseases and the identified gut microbiota. There were no significant associations between the two Male reproductive diseases and the previously identified gut bacteria (Supplementary Tables 1G–I, 2G–I). Cochran’s Q-test showed no heterogeneity.
Enrichment analysis
The gut microbiome enrichment analysis identified 158 regulatory pathways associated with male infertility (Supplementary Table 1J, Fig. 6). The gut microbiome enrichment analysis also identified 198 regulatory pathways associated with abnormal spermatozoa (Supplementary Table 2J, Fig. 7). Thirty significantly enriched pathways were selected.
Discussion
The incidence of male infertility is steadily rising due to the widespread adoption of contemporary lifestyles37. There is insufficient data to determine the precise function played by the gut microbiota in male infertility, despite research indicating that it might be linked to infertility. Therefore, to thoroughly analyse the data and investigate the causal relationship between male reproductive diseases and gut microbiota, we used a two-sample MR technique based on gut microbiota GWAS data. Our study provided a thorough and complete MR examination of our current understanding, looking at the genetic link between the gut microbiota and male reproductive diseases. We identified a genetic susceptibility to gut bacteria that is causally associated with male reproductive disorders, such as male infertility and sperm abnormalities. Overall, we identified 16 different gut bacteria as potential risk factors for these diseases. Our research will contribute to a better understanding of the causal relationship between male reproductive diseases and the gut microbiota, laying a solid scientific foundation for the clinical treatment of these diseases.
Our IVW analysis yielded conclusive findings regarding the causal relationship between the gut microbiota and male infertility at various taxonomic levels, including phylum, class, order, family, and genus. Among them, we identified two families, two genera, and one order that exhibited a negative correlation with male infertility. These are the family Bacteroidaceae (id.918), the family Pasteurellaceae (id.3689), the genus Bacteroides (id.918), the genus Ruminococcaceae NK4A214 group (id.11358), and the order Pasteurellales (id.3688). This is consistent with previous studies. Hao et al. showed that faecal microbiota transplantation could improve the high-fat diet (HFD)-disrupted gut microbiota by increasing Bacteroidales, which in turn improved the damaged testicular microenvironment, rescued spermatogenesis, and improved semen quality and fertility in HFD-treated patients38. Mycobacterium species have a positive impact on male fertility through their influence on spermatogenesis signalling and the gut microbiota-testis axis. Reduced abundance of the Ruminococcaceae NK4A214 cluster might lead to abnormal spermatogenesis by reducing bile acid levels and vitamin A absorption39. Combining the results of our study and a literature search, the family Pasteurellaceae and the order Pasteurellales were not found to be associated with male infertility, which provides a potential new avenue for microbiological studies of male infertility. Furthermore, we found three taxa that showed a positive association with male infertility: the genus Lactococcus (id.1851), the genus Eubacterium oxidoreducens group (id.11339), and the genus Eubacterium ventriosum group (id.11341). Consistent with previous studies, Lactococcus is a risk factor for male infertility21. Eubacterium, which belong to the phylum Firmicutes, are important intestinal bacteria found in the colon of healthy people. Decreased numbers of Eubacterium correlates with many diseases, such as depression and/or fatigue, obesity, inflammatory bowel disease, type II diabetes mellitus, cardiovascular and cerebrovascular diseases, colorectal cancer, autism, senile sarcosis, intestinal health, good tumour prognosis, and intestinal homeostasis40. However, the relationship between Eubacterium and male infertility has not been reported in previous studies.
In this study, 8 gut microbiota members were found to be associated with abnormal sperm. The family Porphyromonadaceae (id.943) and the genus Prevotella9 (id.11183), were found to be negatively correlated with abnormal sperm. Porphyromonadaceae and Prevotella are associated with metabolic syndrome indexes, including atherosclerosis and diabetes, in mice and humans41. They might protect sperm by controlling the body’s metabolic index, thereby reducing chronic inflammation. Six other bacteria correlated positively with abnormal spermatozoa, including the class Erysipelotrichia (id.2147); ebi-a-GCST90016952 (family Streptococcaceae, id.1850); the genus Lachnospiraceae UCG001 (id.11321); the genus Ruminococcaceae UCG009 (id.11366); the genus Streptococcus (id.1853); and the order Erysipelotrichales (id.2148). Certain pathogenic bacteria in the gut, such as Erysipelotrichia, Streptococcus, Lachnospiraceae, Ruminococcaceae, and the order Erysipelotrichales, can produce an endotoxin-induced inflammatory response. The endotoxin binds to human spermatozoa and supports cells’ toll-like receptor-4 (TLR-4), activating the TLR-4-myeloid differentiation primary response protein 88 (MyD88)-dependent pathway, which releases several molecules, such as mitogen-activated protein kinases, interferon-regulating factors, and inducible nitric oxide synthase (iNOS)42. Together, these transcription factors activate and regulate the expression of numerous pro-inflammatory factors that damage the blood-testis barrier’s endothelium, impair spermatogenesis, and ultimately result in male infertility. Furthermore, dysbiosis causes aberrant expression of related genes, such as SYCP genes (encoding synaptonemal complex proteins), which are essential for chromosome binding or segregation, as well as DNA double-strand breaks. Their decreased expression also results in a decrease in the expression of the GGNBP2 gene (encoding gametogenetin binding protein 2), which is necessary for spermatocytes to repair meiotic DNA double-strand breaks43.
The relationship between the gut microbiota and male infertility was substantially influenced by several signalling pathways. Enrichment analyses showed that calcium (Ca2+) signalling controls several crucial stages in the fertilization process, such as sperm overactivation, acrosome response, and sperm-egg fusion. Antonouli et al. demonstrated that several Ca2+-dependent physiological responses during fertilization are mediated by the sperm-specific cation channel CatSper, which is primarily located in the main part of the flagellum of mature spermatozoa. Meanwhile, Ca2+ signalling mediated by CatSper initiates a tyrosine phosphorylation cascade that controls sperm motility44. Therefore, it is reasonable to speculate that gut microbes might cause male infertility by affecting calcium ion binding and calcium ion homeostasis. Furthermore, enrichment analysis revealed that multiple signalling pathways have a significant impact on the link between abnormal spermatozoa and the gut microbiome, including cell activation involved in the immune response; regulation of the immune effector process; negative regulation of the inflammatory response; regulation of T cell activation; regulation of leukocyte cell–cell adhesion; leukocyte activation involved in the immune response; regulation of leukocyte activation; and regulation of the production of molecular mediator of immune response. Duan et al. found that Th17 causes antigen-presenting cells to become chronically inflamed in patients with azoospermia and that T lymphocytes, as regulators, are crucial to the pathophysiology of male infertility45. Losdat et al. conducted related studies on great tits and found that an enhanced immune response affects sperm quality through the damaging effects of oxidative stress46. Therefore, we speculated that the relevant gut microbes might affect sperm by affecting immunity.
To date, there have been few reports on the relationship between the gut microbiota and male fertility. Through MR Analysis, we revealed that the family Bacteroidaceae, the family Pasteurellaceae, the genus Bacteroides, the genus Ruminococcaceae NK4A214 group, and the order Pasteurellales are protective against male infertility. The family Porphyromonadaceae and the genus Prevotella9 were found to correlate negatively with the likelihood of abnormal sperm. These gut bacteria were primarily linked to immunological reactions and calcium ion channels, according to further pathway enrichment analysis. However, the exact mechanism between gut microorganisms and male fertility is unclear and further research is needed. Our analyses demonstrated the existence of a gut-fertility axis, highlighting the interconnectedness and feedback between the two. Disruption of this balance can lead to the development of disease.
Mendelian Randomization is a statistical method based on whole genome sequencing data that is effective in reducing bias, similar to RCT studies, and is used to uncover causal relationships47. The benefits are as follows: first, individual genetic diversity predates the course of disease, eliminating confounding bias resulting from problems with reverse causation; second, the study met all three MR analysis hypotheses and ensured the IVs’ power for MR analysis by obtaining genetic variations of the gut microbiota via the broadest feasible GWAS meta-analysis. Third, the exclusion of pleiotropy was tested using the MR-PRESSO and MR-Egger regression intercept terms. This study has certain limitations. First, the gut microbiome GWAS data came from a varied sample of 18,340 adults from various ethnic backgrounds. Extrapolating the results to other populations with various lifestyles, cultural backgrounds, and genetic backgrounds should be carried out with caution, because the specific traits of different races and ethnic groups might alter due to differences in living circumstances and genetic backgrounds. Second, we employed a public GWAS database that cannot be accessed individually for men and women. We were unable to prevent bias by using subgroup analyses because the analyses employed summary statistics rather than raw data. As a result, this might affect the generalisation of the finding to the male population. Finally, further experimental and clinical validation is required to establish whether a specific microbial species has any appreciable impact on humans, given that the MR analysis is predicated on untestable assumptions.
Conclusion
Using MR analysis, we were able to identify microorganisms linked to two male reproductive diseases, while avoiding the frequent biases seen in observational studies. Our research creates new opportunities for therapeutic intervention with this group of patients. To investigate the precise physiological processes and the role played by bacteria in the pathophysiology of male reproductive diseases, more research is necessary.
Data availability
The article and Supplementary material contain the original contributions made during the study. For additional information, contact the corresponding author.
References
Krausz, C. & Riera-Escamilla, A. Genetics of male infertility. Nat. Rev. Urol. 15, 369–384 (2018).
Bieniek, J. M., Lapin, C. D. & Jarvi, K. A. Genetics of CFTR and male infertility. Transl. Androl. Urol. 10, 1391–1400 (2021).
Katib, A. A., Al-Hawsawi, K., Motair, W. & Bawa, A. M. Secondary infertility and the aging male, overview. CEJU 67, 184 (2014).
Morin-Papunen, L. & Koivunen, R. Treatment of infertility–-Part II (male infertility). Duodecim 128, 1568–1575 (2012).
Wargo, J. A. Modulating gut microbes. Science 369, 1302–1303 (2020).
Massey, W. & Brown, J. M. The gut microbial endocrine organ in type 2 diabetes. Endocrinology 162, 235 (2021).
Wang, S.-Z., Yu, Y.-J. & Adeli, K. Role of gut microbiota in neuroendocrine regulation of carbohydrate and lipid metabolism via the microbiota-gut-brain-liver axis. Microorganisms 8, 527 (2020).
Ramakrishna, B. S. Role of the gut microbiota in human nutrition and metabolism. J. Gastroenterol. Hepatol. 28, 9–17 (2013).
Zhu, B., Wang, X. & Li, L. Human gut microbiome: The second genome of human body. Protein Cell 1, 718–725 (2010).
Rosen, C. E. & Palm, N. W. functional classification of the gut microbiota: The key to cracking the microbiota composition code: Functional classifications of the gut microbiota reveal previously hidden contributions of indigenous gut bacteria to human health and disease. BioEssays 39, 1700032 (2017).
Mahiddine, F. Y., You, I., Park, H. & Kim, M. J. Commensal Lactobacilli enhance sperm qualitative parameters in dogs. Front. Vet. Sci. 9, 888023 (2022).
Elokil, A. A. et al. Investigation of the impact of gut microbiotas on fertility of stored sperm by types of hens. Poult. Sci. 99, 1174–1184 (2020).
Wang, Y. & Xie, Z. Exploring the role of gut microbiome in male reproduction. Andrology 10, 441–450 (2022).
Sanderson, E. et al. Mendelian randomization. Nat. Rev. Methods Primers 2, 6 (2022).
Den Hollander, W. J. et al. Helicobacter pylori colonization and obesity—A Mendelian randomization study. Sci. Rep. 7, 14467 (2017).
Grover, S., Del Greco, M. F., Stein, C. M. & Ziegler, A. Mendelian randomization. In Statistical Human Genetics Vol. 1666 (ed. Elston, R. C.) 581–628 (Springer, 2017).
Emdin, C. A., Khera, A. V. & Kathiresan, S. Mendelian randomization. JAMA 318, 1925 (2017).
Lin, B. D., Li, Y. & Luykx, J. Mendelian randomization concerns. JAMA Psychiatry 75, 407 (2018).
MiBioGen Consortium Initiative. Meta-analysis of human genome-microbiome association studies: The MiBioGen consortium initiative. Microbiome 6, 101 (2018).
Kurilshikov, A. et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat. Genet. 53, 156–165 (2021).
Fu, Z., Wang, Y. & Yan, H. Male infertility risk and gut microbiota: A Mendelian randomization study. Front. Microbiol. 14, 1228693 (2023).
Dai, M. et al. Type 2 diabetes mellitus and the risk of abnormal spermatozoa: A Mendelian randomization study. Front. Endocrinol. 13, 1035338 (2022).
Liu, R., Liu, Q., Xu, S. & Mei, R. Mood instability and low back pain: A Mendelian randomization study. Front. Neurol. 14, 1252329 (2023).
Li, P. et al. Association between gut microbiota and preeclampsia–eclampsia: A two-sample Mendelian randomization study. BMC Med. 20, 443 (2022).
Remmelzwaal, S. et al. Inflammation and heart failure: A two-sample Mendelian randomization study. J. Cardiovasc. Med. 23, 728–735 (2022).
Papadimitriou, N. et al. Physical activity and risks of breast and colorectal cancer: A Mendelian randomisation analysis. Nat. Commun. 11, 597 (2020).
Staley, J. R. et al. PhenoScanner: A database of human genotype–phenotype associations. Bioinformatics 32, 3207–3209 (2016).
Mounier, N. & Kutalik, Z. Bias correction for inverse variance weighting Mendelian randomization. Genet. Epidemiol. 47, 314–331 (2023).
Slob, E. A., Groenen, P. J., Thurik, A. R. & Rietveld, C. A. A note on the use of Egger regression in Mendelian randomization studies. Int. J. Epidemiol. 46, 2094–2097 (2017).
Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304–314 (2016).
Pereira, T. V., Patsopoulos, N. A., Salanti, G. & Ioannidis, J. P. A. Critical interpretation of Cochran’s Q test depends on power and prior assumptions about heterogeneity. Res. Synth. Method 1, 149–161 (2010).
Ong, J. & MacGregor, S. Implementing MR-PRESSO and GCTA-GSMR for pleiotropy assessment in Mendelian randomization studies from a practitioner’s perspective. Genet. Epidemiol. 43, 609–616 (2019).
R Core Team. R: A Language and Environment for Statistical Computing. https://www.R-project.org/ (R Foundation for Statistical Computing, 2020).
Yu, X.-H., Yang, Y.-Q., Cao, R.-R., Bo, L. & Lei, S.-F. The causal role of gut microbiota in development of osteoarthritis. Osteoarthr. Cartil. 29, 1741–1750 (2021).
Huang, D. et al. GWAS4D: Multidimensional analysis of context-specific regulatory variant for human complex diseases and traits. Nucleic Acids Res. 46, W114–W120 (2018).
Dang, K. et al. Transcriptomic and proteomic time-course analyses based on metascape reveal mechanisms against muscle atrophy in hibernating Spermophilus dauricus. Compar. Biochem. Physiol. A Mol. Integr. Physiol. 275, 111336 (2023).
Turner, K. A. et al. Male infertility is a women’s health issue—Research and clinical evaluation of male infertility is needed. Cells 9, 990 (2020).
Hao, Y. et al. Gut microbiota-testis axis: FMT mitigates high-fat diet-diminished male fertility via improving systemic and testicular metabolome. Microbiol. Spectr. 10, e00028 (2022).
Zhang, T. et al. Disrupted spermatogenesis in a metabolic syndrome model: The role of vitamin A metabolism in the gut-testis axis. Gut 71, 78–87 (2022).
Hao, Y. et al. Gut microbiota-testis axis: FMT mitigates high-fat diet-diminished male fertility via improving systemic and testicular metabolome. Microbiol. Spectr. 10, e0002822 (2022).
Chassaing, B., Aitken, J. D., Gewirtz, A. T. & Vijay-Kumar, M. Gut microbiota drives metabolic disease in immunologically altered mice. Adv. Immunol. 116, 93–112 (2012).
Nahid, M. A., Satoh, M. & Chan, E. K. MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol. Immunol. 8, 388–403 (2011).
Li, T. et al. A two-sample Mendelian randomization analysis investigates associations between gut microbiota and infertility. Sci. Rep. 13, 11426 (2023).
Antonouli, S. et al. Sperm plasma membrane ion transporters and male fertility potential: A perspective under the prism of cryopreservation. Cryobiology 114, 104845 (2024).
Duan, Y.-G. et al. Immunodeviation towards a Th17 immune response associated with testicular damage in azoospermic men: Testicular Th17 immune response in azoospermic men. Int. J. Androl. 34, e536–e545 (2011).
Losdat, S., Richner, H., Blount, J. D. & Helfenstein, F. Immune activation reduces sperm quality in the great tit. PLoS ONE 6, e22221 (2011).
Kohlmeier, M. & Baah, E. When Mendelian randomisation fails. BMJNPH 4, 1–3 (2021).
Funding
This work was supported by the Natural Science Foundation of China Youth Project [Grant Number 82101689].
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Han, X., Tian, H., Yang, L. et al. Bidirectional Mendelian randomization to explore the causal relationships between the gut microbiota and male reproductive diseases. Sci Rep 14, 18306 (2024). https://doi.org/10.1038/s41598-024-69179-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-69179-9
Keywords
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.